This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (109)
-
April 02, 2026 | Comment Semaglutide patent expiry exposes global split on access, exclusivity
Sections: Intellectual Property
-
January 29, 2026 | Comment India-EU FTA to force high-speed overhaul of Indian patent law
Sections: Intellectual Property and Trade
-
January 27, 2026 | Press Round-Up United States Antitrust Press Round-Up United States | 27 Jan 2026
Sections: Antitrust and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login